Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy.
about
miR-15 and miR-16 induce apoptosis by targeting BCL2Targeted therapy against Bcl-2-related proteins in breast cancer cellsGenetic variation in BCL2 3'-UTR was associated with lung cancer risk and prognosis in male Chinese populationCo-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis.Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1Death receptor signals to mitochondria.Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL.Regulators of apoptosis: suitable targets for immune therapy of cancer.Bowman-Birk protease inhibitor from soybeans enhances cisplatin-induced cytotoxicity in human mesothelioma cells.Recent advances in haematology and oncology: graft-versus-host disease, classification and treatment of non-Hodgkin's lymphomas, and sentinel-node biopsy in breast cancer.Antisense-based cancer therapeutics: are we there yet?Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.Gene expression signatures of cAMP/protein kinase A (PKA)-promoted, mitochondrial-dependent apoptosis. Comparative analysis of wild-type and cAMP-deathless S49 lymphoma cells.Antiapoptotic Bcl-2 protein as a potential target for cancer therapy: A mini review.Non-coding RNAs as drug targets.Apicidin-resistant HA22T hepatocellular carcinoma cells massively promote pro-survival capability via IGF-IR/PI3K/Akt signaling pathway activation.The Id-protein family in developmental and cancer-associated pathways.Induction of apoptosis by a potent caffeic acid derivative, caffeic acid undecyl ester, is mediated by mitochondrial damage in NALM-6 human B cell leukemia cells.Geraniin induces apoptosis of human breast cancer cells MCF-7 via ROS-mediated stimulation of p38 MAPK.Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs.
P2860
Q24536069-F452FCC9-7C8D-4A14-B2D2-D47D03B545EDQ25257509-05AAA1B4-B3D0-4D0D-9AE0-F742FB0FAF03Q28387362-F5164EE7-5DE6-450C-991D-5931104D57C5Q33523022-F6CD68B0-5261-4CE6-8697-EF0BAB235E4EQ34123184-7344A97B-AFB1-440C-BB4A-5F314A09808DQ34139596-1BF3E9E1-0744-447C-B866-28CF31AAC4BDQ35812718-80804F06-78B9-4164-961A-407EDB4111A9Q36111911-0FE96F66-C843-470A-B916-AB10B7F399E4Q36230707-94AA1BE6-0482-4CAA-9B4D-DA8AE4824213Q36322963-BE639078-B9BB-4117-A59A-48DC846F124EQ36458427-5927BE11-0E40-4251-BFBC-16CA6C59279CQ36680180-F7D88245-E4C1-4BCE-AEF3-D1BFF72E440FQ37439080-AA63A597-382B-4BF2-A8A4-03DE0D5F28DDQ38388106-DFAC0EA4-8E1D-4177-9E22-CA4E8204C2AAQ38904908-EC2A89C4-E16C-40D2-99F8-B617193D3459Q39102933-94971369-6EFE-4D2E-9E49-EFAC5FAF6BB1Q39103288-C82892BF-CA3E-4D44-9768-077F2E36A789Q39228259-EC82B6A8-3D2A-4D5C-82E8-BF22B54D08CCQ46560681-CD96D91B-328E-449B-81F7-DBD8C80F950AQ48569299-E59C1EE0-E3F7-4D14-891D-34B2E23235D1
P2860
Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy.
@ast
Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy.
@en
type
label
Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy.
@ast
Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy.
@en
prefLabel
Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy.
@ast
Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy.
@en
P2093
P356
P1433
P1476
Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy.
@en
P2093
Kazuaki Tanabe
Manabu Emi
Ryungsa Kim
Tetsuya Toge
P304
P356
10.1002/CNCR.20696
P407
P577
2004-12-01T00:00:00Z